dr.sinclair


Showing 2 reactions

Please check your e-mail for a link to activate your account.
  • commented 2016-04-12 10:12:09 -0400
    Swan Valley Medical has developed the T spec, an inside out instrument for accurately placing a suprapubic catheter which is being recommended in the medical literature with greater frequency to prevent CAUTI’s and urethral and epididymal injuries associated with transurethral or Foley catheters. It has been estimated that 3 to 10 percent per day of transurethral catheters are associated with urinary tract infections. Several journal articles have recommended the use of suprapubic catheters to prevent this. The current method of percutaneous punch however, is associated with 4.4 percent mortality and 46 percent morbidity according to the US health and human services survey. This has mainly been secondary to puncturing bowel which may be occult for months before leaking fecal matter into the peritoneum. The T spec, on the other hand has had no deaths and only 1.8 percent morbidity, which has been minimal, in over 900 cases around the United States. There are 25 million transurethral catheters placed in this country each year and 75 million in the rest of the world. The potential for reducing death and morbidity is enormous with the T SPeC.
    The suprapubic catheter has been calculated to reduce urinary tract infections by up to 87 percent. That would represent a reduction in UTIs of 21,750,000 in this country alone, and would reduce the risks of hospitals being penalized by CMR for in-house infections or CAUTIs. in addition, roughly 30 percent of urinary tract infections, if persistent, lead to sepsis, and 2 to 9 percent of those lead to death. On average, this would comprise 1.5 percent of patients. Thus, the T spec placed suprapubic catheter would further add to safety.
    Lastly, there have been many surveys of suprapubic catheter’s which have been preferred over transurethral catheters in 89 percent of patients because of comfort, hygiene, and convenience.
    Wayne Sinclair, M.D.
    Medical Director
    Swan Valley Medical
    207-567-8013
    406-544-7257 cell
  • published this page in Join the Discussion 2016-04-12 10:10:26 -0400

Discussion Forum

Do medical device companies wait too long on recalls?
A study has found an under-reaction to adverse events related to devices. Read a news article from the Minneapolis St...
Groups Protest 28-Hour Shifts for Medical Residents
According to this article in the Chicago Tribune, "Several groups are speaking out against a proposal to allow new do...
Communication Skills Matter for Patients, Too
For patients, practicing good communication skills is often a defensive action. Read this blog post on the EngagingPa...
See All Stories

Patient Safety News

See More News

Twitter: #UnitedForPatientSafety

The National Patient Safety Foundation salutes Mallinckrodt Pharmaceuticals for their generous support of this year's Patient Safety Awareness Week and their ongoing commitment to patient and workforce safety.